You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) CALCIUM SACCHARATE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing CALCIUM SACCHARATE excipient

Market Dynamics and Financial Trajectory for Calcium Saccharate

Last updated: March 24, 2026

What is Calcium Saccharate?

Calcium saccharate is a calcium salt of saccharic acid (glucaric acid). It functions as an excipient, supplement, and stabilizer in pharmaceutical formulations, particularly in calcium and mineral supplements. It also finds use in food and cosmetic industries due to its chelating properties.

Market Overview

Industry Demand Drivers

  • Pharmaceutical Segment: Growing healthcare infrastructure in emerging markets increases demand for mineral supplements that include calcium saccharate. It is used in calcium-fortified formulations, especially in pediatric and elderly nutrition products.

  • Nutritional Supplements: Rise in osteoporosis prevalence worldwide fuels the demand for calcium-based supplements, including calcium saccharate, for its high bioavailability and solubility.

  • Food and Beverage Industry: Calcium saccharate functions as a sequestrant and stabilizer, used in dairy, bakery, and beverage products, driven by clean-label and mineral enrichment trends.

Market Size Estimates

  • The global calcium salts market, including calcium saccharate, was valued at approximately USD 1.5 billion in 2022.

  • Forecasts project a compound annual growth rate (CAGR) of around 4.2% from 2023 to 2030, reaching USD 2.2 billion by 2030 (Research and Markets, 2022).

Geographic Distribution

Region Market Share (2022) Growth Drivers
North America 35% Aging population, health awareness
Europe 25% Fortification regulations, food additive trends
Asia-Pacific 28% Economic growth, supplement consumption, manufacturing boom
Rest of World 12% Market penetration, urbanization

Key Players

Major producers include:

  • Jungbunzlauer: Supplies calcium saccharate for food, pharmaceutical, and cosmetic applications.
  • Roquette: Offers a range of excipients, including calcium derivatives.
  • Merck Group: Provides calcium salts in pharmaceutical-grade specifications.

Regulatory Environment

  • FDA (U.S.): Recognizes calcium saccharate as generally regarded as safe (GRAS) for food use.
  • EFSA (Europe): Similar designation; approved as a food additive and supplement.
  • Pharmaceutical Regulations: Compliance with USP, EP, and JP standards necessary for medicinal applications.

Market Challenges

  • Supply Chain Constraints: Raw material shortages and price volatility of saccharic acid precursor impact availability and costs.
  • Regulatory Hurdles: Varying standards across jurisdictions necessitate adaptation, raising compliance costs.
  • Chemical Stability and Compatibility: Some formulations require modification to maintain stability, limiting broader application.

Financial Trajectory

Cost Structure

  • Raw Materials: Saccharic acid (precursor) accounts for approximately 40% of manufacturing costs.
  • Manufacturing: Energy and purification processes contribute 25%.
  • Regulatory Compliance: Adds 10-15%, especially in markets with strict standards.
  • Distribution: Logistics and storage constitute 20%.

Pricing Trends

  • The average unit price of calcium saccharate in pharmaceutical-grade batch sizes ranges from USD 15 to USD 30 per kilogram, dependent on purity and application volume.
  • Industry trends suggest a progressive reduction in unit price driven by economies of scale and process optimization.

Revenue Projections

  • For companies producing calcium saccharate, projected revenues are expected to grow at a CAGR of 5% between 2023 and 2028.
  • Market expansion, particularly in Asia-Pacific, supports revenue growth.
  • The shift toward plant-based and natural calcium sources may influence pricing and demand patterns.

Investment Outlook

  • Potential investment in production capacity is viable given projected demand growth.
  • R&D investments into bio-based and more sustainable synthesis routes could lower costs and comply with environmental standards.
  • Collaborations with pharmaceutical and food industry players can enhance market penetration.

Key Risks and Opportunities

  • Risks: Price volatility of raw materials, regulatory delays, stiff competition.
  • Opportunities: Growing health awareness, product innovation for targeted delivery, expansion into emerging markets.

Key Takeaways

  • Calcium saccharate's global market is expanding at 4-5% annually, driven by the pharmaceutical, nutritional, and food sectors.
  • Major regions include North America, Europe, and Asia-Pacific, with Asia-Pacific leading growth.
  • Cost and regulatory challenges demand strategic supply chain and compliance management.
  • Market revenues are projected to hit USD 2.2 billion by 2030.

FAQs

1. What are the primary applications of calcium saccharate?
It is used mainly in calcium-fortified pharmaceuticals, nutritional supplements, and as a stabilizer or sequestrant in food and cosmetics.

2. Which regions exhibit the fastest growth?
Asia-Pacific leads with a CAGR of approximately 5%, driven by increased supplement consumption and manufacturing capacity.

3. What factors influence calcium saccharate prices?
Raw material availability, manufacturing efficiencies, regulatory standards, and demand levels impact pricing.

4. What is the outlook for new entrants?
Entry is feasible with scalable production processes and compliance with regional regulatory standards; innovation may provide competitive advantage.

5. How does regulatory approval vary globally?
While recognized as GRAS and approved as a food additive in many jurisdictions, specific application approvals may differ, requiring localized compliance.


References

  1. Research and Markets. (2022). Global Calcium Salts Market Report. [Data file].
  2. U.S. Food and Drug Administration. (2021). GRAS Notice Register.
  3. European Food Safety Authority. (2022). Evaluation Report on Calcium Salts.
  4. Jungbunzlauer. (2023). Product Specifications and Applications.
  5. Roquette. (2023). Custom Excipients for Pharma and Food.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.